Independent single-page institutional briefs on under-covered listed companies across Europe and North America, grouped by sector. Use the sector buttons below to jump to a section, then download any company's full PDF brief.
LOND CAPITAL · Investor Relations · Updated June 2026
Independent single-page institutional briefs on under-covered listed companies across Europe and North America, grouped by sector. Use the sector buttons below to jump to a section, then download any company's full PDF brief.
LOND CAPITAL · Investor Relations · Updated June 2026
Europe's largest carmaker executing a €1bn-per-quarter overhead reduction, on ~6% dividend yield and a deep sum-of-the-parts discount against its Porsche and Audi holdings.
~120 vacation-ownership resorts and ~700,000 owner families on a ~3.7% yield, with post-Q1 restructuring under an interim CEO and a Goldman Sachs upgrade to Buy.
Century-old South African brand champion delivering strong H1 2026 volume growth and operating-income improvement under CEO Tjaart Kruger's reset strategy.
Family-controlled French poultry and ready-meals champion compounding quietly at ~13–14x earnings with net cash — a steady compounder in defensive consumer staples.
US premium recreational boat maker (MasterCraft, Crest, Aviara brands) at a cyclical trough — a discretionary consumer play on the US recreation cycle.
131 years of compounding in taste and scent, an 18.5% EBIT margin business trading ~30% below its 52-week high — a quality compounder at a rare entry point.
Family Banker advisory network compounding at +205% five-year total return, with Q1 net income of €277m, a ~6.7% yield and a strategic Mediobanca stake.
FY 2025 delivered record underlying profit of £98m and a record 3.17% NIM, yet the shares trade at ~14x earnings and roughly 60% below the ~266p consensus target.
Mid-Norway's leading bank at 17.1% CET1 with a ~7% yield, trading below book at ~10x earnings — a high-quality regional franchise at an undemanding valuation.
South-Norway's leading regional bank, formed by the 2025 merger of SR-Bank and SpareBank 1 Sørøst; strong CET1 + ROE profile in the Nordic regional banking sector.
Tanzania's leading bank by assets, loans and deposits — up 260% in a year on a structural frontier re-rating yet still trading at ~10x trailing earnings.
ProntoPegno pawn lending across Italy, Greece and Portugal plus the Art-Rite auction house; H1 profit +100% YoY on €124m of pawn loans, within the Banca CF+ group.
Alternative-asset firm targeting a $1.5bn raise on a downside-protected private-equity hedge-fund model — capital preservation with alternative-market upside.
World's largest reinsurer with diversified primary insurance (ERGO) operations; multi-decade dividend record + record solvency capital and strong reserving discipline.
Wisconsin-based US community bank growing organically and through acquisitions across the upper Midwest — high-performance regional bank at conservative multiples.
Kazakhstan-headquartered diversified financial services group (brokerage, banking, insurance, telecom) with a US listing — frontier-markets growth at developed-market disclosure.
German integrated financial services group serving academic professionals — wealth management, banking and insurance with multi-decade compounding history.
Production set to quadruple to 100,000+ bopd by 2028 across Gabon, Brazil and Namibia — one of the most compelling production-growth stories in listed E&P.
Cooper Basin and South Sumatra producer entering the East Coast Gas Market, with first Vanessa gas under a binding three-year contract with Origin Energy.
4.3GW project pipeline monetising stranded renewable energy for computing, revenue +58% with the Briscoe wind deal closing — a clean-energy + data-infrastructure crossover.
Saxony CERENERGY battery plant where the €46.7m awarded grant exceeds the enterprise value; Silumina Anodes pilot operational — a potential re-rating catalyst.
Renamed Corey Europe in June 2025 and repositioned around microgrid solutions and containerised battery energy-storage systems — a pivotal strategic transformation.
Record Q1 2026 EBITDA of $28.7m from Minera Don Nicolas in Argentina, with the Monte do Carmo feasibility showing US$390m NPV at 34% IRR; +355% over one year.
Fully permitted Alamos silver project with 55Moz AgEq and a 50,000m drill programme under way — one of the largest fully permitted silver projects in Mexico.
100% owner of the Glover Island LPSE deposit with an April 2026 MRE of 121 koz Indicated and 219 koz Inferred, backed by a Dundee Precious Metals investment.
100% owner of Fremont Gold Mine in California with 1.11 Moz M&I and 1.99 Moz Inferred, after the Gold Orogen spin-out listed on the CSE in February 2026.
Consolidator of the Lake Victoria Goldfield, backed by a Barrick equity investment and a strategic Taifa Group partnership — institutional validation at micro-cap.
Eleven Tombstone Belt projects with Rye returning 1.02 g/t over 37m and Crescat Capital backing — a high-optionality Yukon explorer at a micro-cap entry point.
100% owner of Santa Cruz in Brazil — the first new natural-flake graphite mine in the Americas this century — with Phase 2 (25 ktpy) targeted for 2026.
Six-project Ontario and Quebec portfolio with a June 2026 rare-earth discovery of 1,022 ppm TREO over 55.2m at Burchell, plus 10% carried interest in Ring of Fire chromite.
Dallas-based story-stage miner built around the Skull Valley lease and December 2024 acquisitions, with active capital-structure and governance work under way.
US reclamation company with a 32-site Nevada abandoned-mine portfolio holding 2.5m tons of material, BLM approval received Q1 2026, production targeted Q2 2026.
World leader in high-purity cellulose specialties for industrial, food, and pharmaceutical end markets — a specialty materials play with rebound optionality.
The largest US healthcare staffing company by revenue, serving 2,000+ healthcare systems including 87% of the top US systems — a dominant position in a structurally undersupplied sector.
Obefazimod delivered ~50% Week-44 remission versus 10.4% placebo in Phase 3 ulcerative colitis maintenance; €491.6m cash and a US NDA planned for late Q4 2026.
SVN-001 entering Phase 3 for severe alcohol-use disorder — a large unserved indication at a deep-value market cap. A binary catalyst approaching for a neglected area.
Thykamine Phase 3-ready in ulcerative colitis with a 1-for-60 consolidation completed ahead of a planned US listing — a botanical approach to an established indication.
Fingerprint-sweat drug-screening system with 1,000+ readers installed and 450+ customer accounts across 24 countries, plus a saliva glucose biosensor platform.
Two EMA orphan drug designations against an enterprise value of roughly US$3m — an extreme valuation anomaly for a company with regulatory-validated pipeline assets.
World's largest dialysis-services and products company with vertically integrated clinics and equipment manufacturing — a defensive healthcare-services compounder.
Swedish cell-immunotherapy biotech (formerly Immunicum), developing vididencel in AML and other cancer indications — Phase 2 cancer-relapse prevention.
World #1 in loader cranes at 7x earnings versus peer Hiab's 10.5x, with net debt cut by more than €200m — a global market leader at a meaningful valuation discount.
~90-vessel product tanker fleet on a ~8% dividend yield with upgraded full-year guidance — a high-yield shipping franchise with improving earnings visibility.
Global #1 in safety-critical ATC voice communications at ~1.6x EV/Sales versus defence-electronics peers at 2.5–4x — mission-critical niche at a discount.
Global tolling and ITS provider (founded 1892, ~€530m revenue) at an all-time-low share price after a nine-month shortfall, with FY results due 17 June 2026.
22 consecutive years of dividend increases at ~14x earnings near the 52-week low, with medical-packaging M&A optionality — a compounding dividend grower at a cyclical trough.
Sainsbury's-anchored grocery-tech vendor with UK revenue +93%, trading at 0.41x EV/Sales — a high-growth retail-technology niche at a deep revenue multiple discount.
Water-based Hydrochemolytic plastic recycling achieving 75–80% yields, with a first commercial offtake LOI signed — proprietary process technology at the forefront of the circular economy.
Founder-family software and infrastructure-engineering group trading at an all-time-high €4.38 reached in May 2026 — momentum and quality in a founder-led Italian tech champion.
Pure-play air-quality sensing with near-€7m net cash after the OPRA buyback, against a tightening EU regulatory backdrop — a cash-rich micro-cap in a regulatory growth market.
Cleantech capital-equipment niche leader with a Honeywell partnership, trading at 0.9x price-to-sales — a specialist equipment maker with a blue-chip industrial partner.
Leading Swiss + DACH integrated RE + construction services group; 3 divisions (Buildings + Civil Engineering + Service Solutions); FY 2025 revenue CHF 3,475m / op income CHF 140.5m.
International cement and building-materials producer with operations in US, Greece, SE Europe and Egypt — Mediterranean cement + US infrastructure exposure.
Converting waste hemp biomass into automotive and industrial materials, with Toyota, Winnebago and Gurit partnerships, ~$40m Series B and a $10m Alberta grant.
Six coastal infill logistics markets at 96.3% occupancy with consistent rent mark-to-market gains — a best-in-class industrial REIT in the most supply-constrained US logistics markets.
Zurich-listed German residential RE; FY 2024 LTV 50.9%; Dec 2025 sold ~2,000 units in 25 cities (~38% of Non-Strategic Portfolio); March 2026 preliminary FY 2025 positive + convertible bond tender.
Design and licensing leader in mobile system-on-chip (Snapdragon) and the dominant 5G IP franchise, with accelerating IoT, automotive and PC diversification.
Wafer-cleaning leader whose FY 2026 operating profit of ¥122.5bn beat guidance, with a sector-leading 30% Q4 margin in semiconductor production equipment.
Q1 revenue +14% with a $100m buyback and founder Nirav Tolia back as CEO driving the platform relaunch — a founder-led turnaround with meaningful capital return.
Pivoting to the MIRA compliance-subscription platform with Q2 revenue +27% YoY and Ontario's Bill 190 cleaning-records mandate as a regulatory tailwind.
Post-reorganisation sports-betting ecosystem combining proprietary AI algorithms, blockchain payments and a patented automated poker table — a multi-vertical technology play.
Former gold shell pivoted to modular AI data-centre development with an aggressive site-acquisition pipeline — riding the AI infrastructure wave from micro-cap.
Virtual-tour and spatial-computing platform play, positioned against the Matterport/CoStar acquisition precedent — institutional-grade exit benchmark for the sector.
Lond Capital is an independent investor relations agency arranging unconflicted institutional roadshow programmes for listed companies on a flat-fee basis — no broker conflicts, no success fees.